Evaluation of HER2 Status by Quantitative RT-PCR with Internal Specimen Quality Controls in Breast Cancer

被引：0
|
作者：
Lin, Y. [1 ]
Yu, R. [2 ]
Hsu, W. [1 ]
Liu, Y. [3 ]
Chiu, K. [2 ]
Yeh, Y. [1 ]
机构：
[1] Gen Biol Corp, Hsinchu, Taiwan
[2] Genet Dev Corp, Lake Bluff, IL USA
[3] Curiemed Corp, Hsinchu, Taiwan
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2016年 / 18卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
S21
引用
收藏
页码：1003 / 1003
页数：1
相关论文
共 50 条
  • [31] Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
    Rosa, Fabiola E.
    Silveira, Sara M.
    Silveira, Cassia G. T.
    Bergamo, Nadia A.
    Moraes Neto, Francisco A.
    Domingues, Maria A. C.
    Soares, Fernando A.
    Caldeira, Jose R. F.
    Rogatto, Silvia R.
    BMC CANCER, 2009, 9
  • [32] Histopathological characteristics of breast cancer and evaluation of ER alpha and Her-2neu using immunohistochemical and RT-PCR techniques
    El-Abd, Eman
    Matta, Cecil A.
    Sheta, Manal
    El-Kerm, Yasser
    Sakr, Shimaa
    ALEXANDRIA JOURNAL OF MEDICINE, 2014, 50 (03) : 275 - 282
  • [33] Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
    Fabíola E Rosa
    Sara M Silveira
    Cássia GT Silveira
    Nádia A Bérgamo
    Francisco A Moraes Neto
    Maria AC Domingues
    Fernando A Soares
    José RF Caldeira
    Silvia R Rogatto
    BMC Cancer, 9
  • [34] Real-time RT-PCR: A complementary method to detect HER-2 status in breast carcinoma
    Bossard, C
    Bieche, I
    Le Doussal, V
    Lidereau, R
    Sabourin, JC
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4679 - 4683
  • [35] Early detection of breast cancer in core biopsies by means of quantitative RT-PCR
    不详
    BREAST, 2005, 14 : S51 - S51
  • [36] Status evaluation of HER2 in breast cancerology by immunohistochemistry
    Bekkouche, Z.
    Kahia-Tani, S.
    BULLETIN DU CANCER, 2007, 94 (06) : 571 - 571
  • [37] PROGNOSTIC VALUE OF CTCS FOR MONITORING RESPONSE TO ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER USING RT-PCR FOR CK19 AND HER2
    Ignatiadis, M.
    Xenidis, N.
    Perraki, M.
    Apostolaki, S.
    Piette, F.
    Buyse, M.
    Lianidou, E.
    Sotiriou, C.
    Georgoulias, V.
    Mavroudis, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 78 - 79
  • [38] Detection of circulating tumor cells in breast cancer patients: Preliminary validation of a semi-nested RT-PCR assay for HER2/neu
    Wasserman, LM
    Wallace, A
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05): : 1662 - 1662
  • [39] Evaluation of HER2 status in human breast carcinoma
    Suzuki, T
    Tazawa, C
    Miura, H
    Nakabayashi, M
    Moriya, T
    Sasano, H
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2003, 36 (01) : 1 - 7
  • [40] Automatization of HER2 Status Assessment in Breast Cancer
    Makhov, Denis
    Samorodov, Andrey
    Slavnova, Elena
    2019 URAL SYMPOSIUM ON BIOMEDICAL ENGINEERING, RADIOELECTRONICS AND INFORMATION TECHNOLOGY (USBEREIT), 2019, : 171 - 173
12345